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A second distinct family of anion exchangers, SLC26,
in addition to the classical SLC4 (or anion exchanger)
family, has recently been delineated. Particular interest
in this gene family is stimulated by the fact that the
SLC26A2, SLC26A3, and SLC26A4 genes have been rec-
ognized as the disease genes mutated in diastrophic dys-
plasia, congenital chloride diarrhea, and Pendred syn-
drome, respectively. We report the expansion of the
SLC26 gene family by characterizing three novel tissue-
specific members, named SLC26A7, SLC26A8, and
SLC26A9, on chromosomes 8, 6, and 1, respectively. The
SLC26A7–A9 proteins are structurally very similar at
the amino acid level to the previous family members and
show tissue-specific expression in kidney, testis, and
lung, respectively. More detailed characterization by
immunohistochemistry and/or in situ hybridization lo-
calized SLC26A7 to distal segments of nephrons,
SLC26A8 to developing spermatocytes, and SLC26A9 to
the lumenal side of the bronchiolar and alveolar epithe-
lium of lung. Expression of SLC26A7–A9 proteins in Xe-
nopus oocytes demonstrated chloride, sulfate, and oxa-
late transport activity, suggesting that they encode
functional anion exchangers. The functional character-
ization of the novel tissue-specific members may pro-
vide new insights to anion transport physiology in dif-
ferent parts of body.
The systematic characterization of gene families using full
genome sequences provides a rich source for expanding our
physiological understanding of body functions. Recently, a sec-
ond distinct family of anion exchangers, SLC26, has been de-
lineated. The members of the SLC261 family are structurally
well conserved across different species and can mediate the
electroneutral exchange of Cl for HCO3
 across the plasma
membrane of mammalian cells like members of the classical
SLC4 (anion exchanger) family (1–3). Specific interest in the
SLC26 gene family is stimulated by the fact that the first three
human genes are associated with phenotypically distinct reces-
sive diseases. The SLC26A2, SLC26A3, and SLC26A4 genes
have been recognized as disease genes mutated in diastrophic
dysplasia, congenital chloride diarrhea, and Pendred syn-
drome, respectively (4–6). Thus, the three closely related but
highly tissue-specific human anion transporters play central
roles in the etiology of phenotypically very different recessive
diseases.
In human, six tissue-specific genes of the SLC26 family have
been cloned so far, namely SLC26A1–A4 (previously known as
SAT-1, DTDST, CLD or DRA, and PDS, respectively),
SLC26A6, and TAT1. The SLC26A2–A4 members have been
shown to transport, with different specificities, the chloride,
iodide, bicarbonate, oxalate, and hydroxyl anions (7–12).
SLC26A5 has been cloned from gerbil and rat and shown to act
as a motor protein of cochlear outer hair cell; it is sensitive to
intracellular anions but has not been found to act as a trans-
porter (13, 14). The SLC26A6 protein is expressed at highest
levels in the kidney and the pancreas and suggested SLC26A6
as a candidate for a yet unknown cystic fibrosis transmem-
brane-regulated protein responsible for the luminal anion ex-
changer activity in pancreas (7, 15). The newest member,
TAT1, has been shown to act as a sulfate transporter in human
male germ cells and has been linked to RhoGTPase signaling
(16).
Our observation that the first fully sequenced animal, Cae-
norhabditis elegans, has seven members of this gene family
prompted us to hypothesize that many more than three genes
with important physiological functions might exist also in hu-
man (2). By a homology approach, five novel loci were identified
with distinct tissue expression patterns (7). In this study, we
have characterized two previously mapped candidates in the
chromosomes 8 and 6 and a novel gene in chromosome 1,
named SLC26A7–A9, respectively (Table I). The SLC26A7–A9
proteins show a high degree of similarity to the previous tissue-
specific family members and are expressed at the highest level
in kidney, testis, and lung, respectively. Functional expression
of SLC26A7–A9 in Xenopus laevis oocytes demonstrated chlo-
* This study was supported by the Academy of Finland, Duodecim
Foundation, Ella and Georg Ehrnrooth Foundation, Finska La¨karesa¨ll-
skapet, Sigrid Juselius Foundation, Foundation for Pediatric Research,
Ulla Hjelt Fund, HUCH research funds, the National Health and Med-
ical Research Council of Australia (to D. M.), the Wihuri Foundation,
Oskar O¨flund Foundation, and Research and Science Foundation of
Farmos. The costs of publication of this article were defrayed in part by
the payment of page charges. This article must therefore be hereby
marked “advertisement” in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted
to the GenBankTM/EBI Data Bank with accession number(s) AF331521,
AF331522, and AF331525.
‡‡ To whom correspondence should be addressed: Karolinska Insti-
tute, Dept. of Biosciences at Novum, 14157 Huddinge, Sweden. Tel.:
358-50-5319123; Fax: 46-8-7745538; E-mail: juha.kere@biosci.ki.se.
1 The abbreviations used are: SLC26, solute carrier family 26; DIDS,
diisothiocyanodisulfonylstilbene; PDZ, PSD-95/Disc-large/Z-1; STAS,
sulfate transporter and anti--factor antagonists; ST, sulfate trans-
porter family domain; aa, amino acid; RT, reverse transcriptase.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 277, No. 16, Issue of April 19, pp. 14246–14254, 2002
© 2002 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www.jbc.org14246
 at UQ Library on October 16, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
ride, sulfate, and oxalate transport activities. The functional
characterization of the novel tissue-specific members may pro-
vide new insights to anion transport physiology in different
parts of the body.
EXPERIMENTAL PROCEDURES
Computational Sequence Analysis—The SLC26A7 and -A8 genes
were identified and mapped as described before (7). SLC26A9 was first
found by searching for the sulfate transport motif (PS01130) of the
human SLC26A3 protein against NCBI’s high throughput genomic
sequence (htgs) data base with TBLASTN algorithm (17–19). GEN-
SCAN was used to predict the coding regions from genomic clones
(20–22). Multiple alignment of the protein sequences was done by
ClustalX and BoxShade Server 3.21 (www.ch.embnet.org/software/
BOX_form.html). Putative N-glycosylation sites were analyzed by the
PROSITE program (23). Transmembrane topologies of the
SLC26A7–A9 proteins were predicted by the TMHMM (24) and PSIpred
programs (25).
Cloning of SLC26A7–A9 cDNAs—The coding region of each gene was
assembled from several overlapping PCR fragments, which were am-
plified by gene-specific primers designed to GENSCAN-predicted exons.
The primer sequences can be obtained from the authors
(hannes.lohi@helsinki.fi and juha.kere@biosci.ki.se). The overlapping
PCR fragments were amplified by PCR from the first strand cDNAs of
human kidney, testis, and lung. The first strand cDNAs were synthe-
sized from 1 g of poly(A) RNA (CLONTECH, Palo Alto, CA) by the
SMART RACE cDNA Amplification Kit (CLONTECH) according to the
manufacturer’s instructions. The SMART RACE method was used for
amplification of the 5 and 3 ends of the SLC26A7–A9 cDNAs by PCR.
The following antisense primers were used with the universal primer
mix for 5-rapid amplification of cDNA ends: 5-ATA AGA ATT CAA
GCT TTG ACA TTG-3 and 5-ACT TTG AAA TGC AAA GGA TCC
ACG-3for A7; 5-GGA CTT AGA GCT GAA GCC AGA GAT-3 and
5-CTG AAG GTG GTG ATG TTG ATG TTC-3for A8; and 5-CCA GCC
GGC TTT GCT CAC CCA CTG GCA-3 and 5-CTT GTG GGA CCT
GGA TGG ATC CCC-3for A9. The following sense primers were used
for 3-rapid amplification of cDNA ends: 5-ACC CTG CAG CAG GTG
AAA ATT ATC-3 and 5-CTA ATT CAG TAT AGA ATA TGC TGT TTG
GCA-3 for A7; 5-CTG GCC TAT GTA TCA TCC GTC TAT GGC TTC
for A8; and 5-GAA GGT CAC AGA GCC TCA GGA ATT TCC-3 and
5-GGT TGA AGC AGG AAA GAT GGA GGC AAA-3 for A9. The
cloning of the 3 ends of the genes was also verified by PCR with primers
designed to the regions, which matched the expressed sequence tags
(EST) annotated in GenBankTM. PCRs were done in 25-l volumes
using 5 l of cDNA as template, 10 pmol of each primer, 1 reaction
buffer, 0.2 mM of each nucleotide, and 1 unit of Advantage Polymerase
Mix (CLONTECH) using the following conditions: 94 °C for 3 min, 35
cycles of 94 °C for 30 s, and 68 °C for 1–2 min, followed by 72 °C for 10
min. PCR products were subcloned to pCR-2.1 plasmid (Invitrogen) and
sequenced using dye-terminator chemistry (26) and an automated se-
quencer (ABI 373A, Applied Biosystems, Inc.).
Northern Analysis—Northern analysis was done using the CLON-
TECH (Palo Alto, CA) MTN Northern blots (MTN 7780-1 and MTN
7760-1). A 1984-bp PCR-amplified probe corresponding to nt 198–2181
of SLC26A7, a 551-bp probe corresponding to the 5 sequence from nt
156–707 of SLC26A8, and a 2362-bp probe corresponding to the open
reading frame sequence from nt 115–2476 of SLC26A9 were radiola-
beled with [32P]dCTP with Rediprime Kit (Amersham Biosciences) ac-
cording to the manufacturer’s instructions. The specific probes were
hybridized to Northern blot filters in ExpressHyb solution (CLON-
TECH) for about 2 h to overnight, followed by washes with 2 SSC,
0.1% SDS at room temperature to 65 °C for several hours. Autoradiog-
raphy was performed on x-ray films at 20 °C.
PCR Analyses of SLC26A7–A9 Genes—PCR analyses were done as
above using cDNAs from CLONTECH’s human multiple tissue cDNA
panels I and II (K1420–1 and K1421–1) with the following primers:
5-AAT GGA CAG TGA AAC CCT GCA GCA G-3 and 5-GGA AGC
TGT ACA ATG GGC TAA CAA T-3 from A7; 5-GGA TGT GTA TGT
ATC GAT TAA AGG ATT-3and 5-GGG AAC TTG CAC AAG GCC AAC
AC-3 for A8; and 5-GAG CAG AGC CCT TTC ACA CAC CTC-3 and
5-CTT GTG GGA CCT GGA TGG ATC CCC-3for A9. The primers for
GADPH were included in the kit. The expression of SLC26A9 was
analyzed from two human lung-specific epithelial cell lines, NCI-H358
and A549 (ATCC, Manassas, VA) by RT-PCR. The first strand cDNA
was synthesized from 1 g of total RNA by the SMART RACE cDNA
Amplification kit (CLONTECH) according to manufacturer’s instruc-
tions. PCR was done as above with the following primers: 5-CTC AGC
CAA GAT CAA AGC TGT GGT-3 and 5-GAC GAT GGA CCC TGG
GCC TGT GTA-3. PCR products were verified by sequencing.
In Situ Hybridization—A 538-bp fragment corresponding to posi-
tions 1629–2166 of the SLC26A8 cDNA was generated by PCR and
used to transcribe sense and antisense RNA probes (27). Formalin-
fixed, paraffin-embedded specimens of adult human testes were ob-
tained from the Department of Pathology, Haartman Institute, Univer-
sity of Helsinki. Deparaffinized 5-m tissue sections were digested with
1 g/ml proteinase K for 30 min at 37 °C and treated with 0.1 M
triethanolamine buffer containing 0.25% acetic anhydride for 10 min at
room temperature. Sections were hybridized with 35S-labeled probes
(4  105 cpm/l of hybridization buffer) at 52 °C overnight. The slides
were then washed under stringent conditions with buffer containing
RNase A (28), dipped to LM-1 emulsion (Amersham Biosciences), and
exposed for 10–30 days at 4 °C. The slides were developed and coun-
terstained with hematoxylin and eosin. The sense RNA probe was used
as a negative control.
Immunohistochemistry—Antisera were raised in rabbits against syn-
thetic peptides SHIHSNKNLSKLSDHSEV for SLC26A7, VEEVW-
LPNNSSRNSSPGLPD for SLC26A8, and ELSLYDSEEDIRSYWD-
LEQE for SLC26A9 corresponding to amino acids 639–656, 680–699,
and 758–777, respectively. Two rabbits were immunized per each pep-
tide, and both sera were used in parallel in the experiments giving
similar results. Peptide synthesis and antibody production were pur-
chased from Sigma. Formalin-fixed, paraffin-embedded archival speci-
TABLE I
The SLC26 family of human anion transporters
The chromosomal locations of SLC26A10 and -A11 are known, but the genes remain poorly characterized.
Gene symbol Chromosomelocation
Major sites of
expression Diseases
Sequence
accession
SLC26A1 (SAT1) 4p16 Liver, pancreas,
brain, kidney
Not known AF297659
SLC26A2 (DTDST) 5q32 Ubiquitous DTD, OMIM 222600
ACGIB, OMIM 600972
AOG2, OMIM 256050
U14528
SLC26A3 (CLD,
DRA)
7q22–q31.1 Ileum, colon,
seminal vesicle,
eccrine sweat
gland
Congenital chloride
diarrhea, OMIM
214700
L02785
SLC26A4 (PDS) 7q22–q31.1 Thyroid, kidney,
cochlea
Pendred syndrome,
OMIM 274600
AF030880
SLC26A5 (Prestin) 7 Outer hair cells of
the cochlea
Not known AC005064,
AF230376
for gerbil
SLC26A6 3p21 Kidney, pancreas Not known AF279265
SLC26A7 8q21 Kidney Not known AF331521
SLC26A8 (TAT1) 6p21 Testis Not known AF331522
SLC26A9 1q32 Lung Not known AF331525
SLC26A10 12q14 Brain, other? Not known AF331523
SLC26A11 17q25 Ubiquitous Not known AF331524
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mens of adult human kidney, testis, and lung were obtained from the
Department of Pathology, Haartman Institute, University of Helsinki.
Deparaffinized 5-m tissue sections were pretreated in 0.3% H2O2 for
30 min to block the endogenic peroxidase activity. The antisera were
diluted 1:1000–1:2000. The peroxidase-antiperoxidase technique was
performed utilizing the Vectastain Elite ABC Kit (Vector Laboratories).
Diaminobenzidine was used as the chromogenic substrate, and the
slides were counterstained with Mayer hematoxylin. Preimmune serum
for each immunized rabbit was used as the corresponding negative
control, with similar dilutions to the antisera.
Functional Transport Measurements in X. laevis Oocytes—Mature X.
laevis females were purchased from the African Xenopus Facility C.C.,
Noordhoek, South Africa. Stage V and VI oocytes from X. laevis were
maintained at 17 °C in modified Barth’s solution (88 mM NaCl, 1 mM
KCl, 0.82 mM MgSO4, 0.4 mM CaCl2, 0.33 mM Ca(NO3)2, 2.4 mM
NaHCO3, 10 mM HEPES/Tris, pH 7.4, gentamycin sulfate 20 mg/liter).
Oocytes were injected with either 50–100 nl of water (control) or 7–12
ng of SLC26A7–A9 cRNA using a Nanojet automatic injector (Drum-
mond Scientific Co., Broomall, PA). For cRNA synthesis, pcDNA3.1:
SLC26A7 or pcRII:SLC26A7, pcDNA3.1:A8 or pNKS2:SLC26A8, and
pcRII:SLC26A9 plasmids were linearized by EcoRV, NotI, or XhoI di-
gestions; the cDNAs were in vitro transcribed using T7 or SP6 RNA
polymerases (Promega), and the resulting capped cRNA was dissolved
in MilliQ water before use. Transport of [35S]sulfate, [36Cl]chloride,
and [14C]oxalate uptake was performed 3 days after injection. Briefly,
10 oocytes (per data point) were washed at room temperature for 1–2
min in solution A (115 mM sodium gluconate, 2.5 mM potassium gluco-
nate, 4 mM calcium gluconate, 10 mM HEPES/Tris, pH 7.4) or solution
B (100 mM choline chloride, 4 mM KCl, 2 mM CaCl2, 2 mM MgCl2, and 20
mM Hepes/Tris, pH 7.5) and then placed into 100 l of solution A
containing 2.5 mM NaCl with 36Cl or 0.1 mM oxalate with 2–5 Ci/ml
[14C]oxalate, or into 100 l of solution B containing 0.1 mM K2SO4 with
10 Ci/ml 35SO4
2 (PerkinElmer Life Sciences) for 30–60 min at room
temperature. The oocytes were washed 4 times with ice-cold solution B,
lysed with 4% SDS, dissolved in scintillant (BCS, Amersham Bio-
sciences), and counted by liquid scintillation spectrometry. Inhibition of
the sulfate uptake of SLC26A9 was performed by adding either 1 mM
DIDS, 5 mM thiosulfate, 5 mM oxalate, or 5 mM glucose to the uptake
solution B. All isotopes were purchased from PerkinElmer Life Sci-
ences. Statistical analyses of the transport results were performed
using the prism statistic package, version 3.0 (GraphPad software Inc.,
San Diego, CA). The degree of statistical significance between two
groups was calculated using the unpaired t test, with p  0.05 consid-
ered significant.
RESULTS
Characteristics of SLC26A7—Previously, the SLC26-related
EST AA992584 was identified and mapped to chromosome 8.
Its expanded sequence matched the human genomic draft se-
quence RP11-353D5, which was subjected to exon prediction
(7). Exons predicted by GENSCAN were verified by sequencing
the overlapping PCR fragments. The 5- and 3-regions of the
gene were expanded by RT-PCR. The combined data revealed
an open reading frame of 1971 bp encoding a 656-amino acid
protein. The complete cDNA sequence has been submitted to
GenBankTM (accession number AF331521) and designated
SLC26A7 (nomenclature for all three genes verified with the
HUGO Nomenclature Committee).
The sequence flanking the putative ATG translation start
site (GAAAAATGACA) contains the 3 purine but not 4
guanine residues of the Kozak consensus sequence (29), and
four in-frame stop codons precede that methionine. A 3024-bp
3-untranslated region precedes the consensus polyadenylation
signal AATAAA. However, several alternative poly(A) signals
were identified at the 3 end of the SLC26A7 composite se-
quence. Exon-intron boundaries were determined by aligning
the cDNA sequence with genomic clones from the Human Ge-
nome Project and Celera Genomics (PAC clone RP11–353D5,
GenBankTM accession number AC017061 and Celera’s clone
GA_x2HTBL2W902, respectively) (30). The open reading frame
was distributed across 19 exons ranging in size from 55 to 306
bp. All exon-intron boundaries obey the general AG-GT rule,
and 10 of 19 exons are exactly the same size as those of the
SLC26A3 and SLC26A4 genes that share 15 exons of similar
size with each other (Table II). The total length of the gene
spans about 100 kb of genomic sequence.
The SLC26A7 protein shows 50% similarity to SLC26A2 and
A3 proteins (BLASTP E value 1  1080), and the multiple
alignment of the proteins reveals a large number of conserved
residues (Fig. 1). PROSITE predicted two putative N-glycosy-
lation sites for SLC26A7 at Asn125 and Asn131. The 10- or
12-transmembrane structure with intracellular N- and C-ter-
minal domains was suggested by the TMHMM and PSIpred
program, resembling the topology predicted for the SLC26A3
protein (2). ProfileScan analysis of the SLC26A7 protein se-
quence revealed two domains, which are also commonly shared
within the other SLC26 family members (Table III): sulfate
transporter family domain (ST family, predicted between aa
200 and 500, PF00916) and sulfate transporters and anti--
factor antagonists (STAS, between aa500 and 700, PS50801).
The putative NTP-binding STAS domain suggests that anion
transport could be regulated by intracellular nucleotides (31).
In addition, C terminus of the SLC26A7 protein (SEV) com-
prises the consensus PDZ interacting motif (T/S)X, where is
a hydrophobic amino acid (32). The PDZ domain proteins play
an essential role in maintaining the cell polarity and function
(33–35).
Characteristics of SLC26A8—Previously, using a homology
approach we identified an SLC26-related genomic sequence
(PAC clone 179N16) in chromosome 6, which predicted a ho-
mologous 300-amino acid N-terminal sequence of the protein by
GENSCAN (7). Later, another genomic sequence (PAC clone
RP11–482O9, accession AL133507) appeared in GenBankTM to
the same region allowing us to predict the C terminus of the
gene. Primers were designed for the predicted exons, and they
were verified by sequencing the overlapping PCR fragments.
The 5- and 3-regions were expanded and verified by RT-PCR.
Sequence analysis revealed an open reading frame of 1971 bp
encoding a 970-amino acid protein. The complete cDNA se-
quence has been submitted to GenBankTM (accession number
AF331522), and the gene was designated SLC26A8. While our
work was in progress, another group (16) reported also the
characterization of the TAT1 gene and protein (for testis-spe-
cific anion transporter-1), which is identical to our SLC26A8.
The full-length cDNA sequence of the SLC26A8 gene spans
about 80 kb of genomic sequence. The open reading frame is
distributed across 20 exons ranging in size from 49 to 369 bp.
TABLE II
Conservation of the exon structure of the human SLC26 family members
SLC26A1 and -A2 are not included, because they have only 3 or 4 exons, respectively. The human SLC26A5 is not known. The numbers refer
to the number of nucleotides in the exons.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
SLC26A3 107 219 140 111 188 165 153 83 148 114 78 96 107 70 93 96 234 55 146 67 21
SLC26A4 221 167 140 111 185 165 153 83 148 114 78 96 107 70 93 96 231 55 146 84 23
SLC26A6 159 140 111 152 165 153 83 148 114 78 96 107 70 93 118 93 177 55 137 15
SLC26A7 96 306 111 173 165 153 83 148 114 78 96 107 67 138 49 101 55 104 36
SLC26A8 110 190 140 116 162 165 150 83 148 114 78 96 107 70 93 132 369 55 185 441
SLC26A9 96 142 140 111 176 165 153 83 148 114 78 96 107 70 93 114 282 55 146 72 48
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FIG. 1. Multiple alignment of the human SLC26 family. Identical and similar amino acids are shaded in black and gray, respectively.
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Exon-intron boundaries obey the general AG-GT rule. The se-
quence around the putative ATG translation start site (AG-
GAATGGCA) contains the 3 purine and 4 guanine residues
of the Kozak consensus sequence (29). A 361-bp 3-untrans-
lated region precedes the consensus polyadenylation signal
AATAAA. A number of exons show conservation of the size,
although there are more variations when compared with the
other family members (Table II).
The SLC26A8 protein shows the best sequence similarity to
SLC26A3 and SLC26A6 (BLASTP E value  2  1078 and 1
 1073, respectively). The overall amino acid similarity of
SLC26A8 to the known members is over 50%, and multiple
alignment of the proteins (Fig. 1) demonstrates the presence of
conserved blocks among the proteins. SLC26A8 protein has
200–300 amino acids more than the other group members, and
SLC26A8-specific extra sequences were found between amino
acids 600–652 and C-terminal regions. However, comparison
of the SLC26A8 protein with other family members reveals
several unconserved residues (Fig. 1). Altogether eight putative
N-glycosylation sites were found along the protein at Asn52,
Asn192, Asn277, Asn384, Asn595, Asn651, Asn687, and Asn688. The
11-transmembrane structure of the SLC26A8 protein with in-
tracellular N-terminal domain and extracellular C-terminal
domain was predicted by the TMHMM program, whereas
FIG. 2. Tissue-specific expression of SLC26A7–A9 genes by Northern blot and PCR analyses. A, SLC26A7; B, SLC26A8; C, SLC26A9.
The expressions of -actin and GADPH genes are shown as controls for Northern blots and multiple tissue panels, respectively. S. muscle, skeletal
muscle; S. intestine, small intestine.
TABLE III
Analysis of the conserved domains within the SLC26 family members by ProfileScan
Match scores are shown in cells. ST family, sulfate transporter family domain; STAS, sulfate transporters and anti--factor antagonists; ST
signat, sulfate transporter signature; NLS BP, nuclear localization bipartite signal; XAN UR perm, xanthine/uracil permeases family; PROK
lipopro, prokaryotic membrane lipoprotein lipid attachment site; PDZ, PSD-95/Disc-large/ZO-1 domain;  is a hydrophobic amino acid. More
detailed descriptions of the profiles can be found by searching the prosite and pfam databases (www.expasy.ch/prosite/ and www.sanger.ac.uk/
Software/Pfam/index.shtml, respectively) with the profile accession numbers provided in the second column. For PDZ motif see Ref. 32.
Domain Profile A1 A2 A3 A4 A5 A6 A7 A8 A9
ST family PF00916 36.5 39.5 37.8 33.5 33.5 34.9 29 27.1 29.4
STAS PS50801 18.4 18.1 14.7 18.8 16.7 10.9 17.6 11.6 17.4
ST signat PS01130 1.0 1.0 1.0 1.0     
NLS BP PS50079   3.0  3.0   3.0 
XAN UR perm PF00860   8.5 8.6  8.5 9.2 9.5 
PROK lipopro PS00013 1.0  1.0 1.0 1.0  1.0 1.0 1.0
PDZ T/S-X-         
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PSIpred failed to predict any structures for the protein. Pro-
fileScan analysis of the SLC26A8 protein sequence found ST
(aa 212–521) and STAS (aa 544–791) domains.
Characteristics of SLC26A9—A homology search with the
sulfate transport signature motif of the human SLC26A3 pro-
tein against NCBI’s htgs data base with TBLASTN algorithm
resulted in an interesting match (E value  0.001) in the
genomic PAC clone RP11–370I5 (GenBankTM accession num-
ber AL360009) in chromosome 1. Subsequently, the genomic
sequence was subjected to GENSCAN for exon prediction, and
the predicted exons were verified by sequencing the overlap-
ping PCR fragments. The 5- and 3-regions were expanded by
the SMART RACE technique. The complete cDNA sequence
includes an open reading frame of 2373 bp encoding a 791-
amino acid protein. The complete cDNA sequence has been
submitted to GenBankTM (accession number AF331525) and
designated SLC26A9.
The sequence around the putative ATG translation start site
(CAGATATGAGC) contains the 3 purine but not 4 guanine
residues of the Kozak consensus sequence (29). A 115-bp un-
translated region including the first exon precedes that methi-
onine. Moreover, a putative TATA box was found 25 bp up-
stream from the first untranslated exon. A 2308-bp 3-
untranslated region precedes the consensus polyadenylation
signal AATAAA. The total length of the gene spans about 25 kb
of the genomic sequence. The open reading frame is distributed
across 21 exons ranging in size from 55 to 282 bp. Exon-intron
boundaries obey the general AG-GT rule, and 14 of 20 exons are
exactly of the same size as those of the SLC26A3 and SLC26A4
genes. Furthermore, PCR analysis proposed two alternatively
spliced variants for SLC26A9 (Fig. 2C). Sequencing revealed
that the second or fourth exon of SLC26A9 is spliced out, which
results in the truncation of the first 89 N-terminal amino acids
or the deletion of amino acids 90–126 (37 residues) of the
protein, respectively.
The SLC26A9 protein is highly conserved with the known
family members as shown in multiple alignment of the proteins
(Fig. 1). SLC26A9 has two putative N-glycosylation sites at
Asn153 and Asn156. ProfileScan analysis of the SLC26A9 pro-
tein sequence revealed ST (aa 187–497) and STAS (aa 520–
733) domains. The C terminus of the SLC26A9 protein (TAL)
comprises the consensus PDZ-protein interacting motif (Table
II). The 9-transmembrane structure of the protein with intra-
cellular N-terminal domain and extracellular C-terminal do-
main was suggested by the PSIpred and TMHMM programs.
Expression Profiles of SLC26A7–A9—The tissue distribution
of the SLC26A7 gene was determined by Northern hybridiza-
tion and PCR using CLONTECH’s multiple tissue cDNA pan-
els with 16 different tissues. The 5250-bp full-length cDNA of
SLC26A7 corresponds well with the observed size (5 kb) in
Northern analysis, and it revealed a specific tissue distribu-
tion, with most abundant expression in the kidney (Fig. 2A). A
weaker 3.0-kb transcript was also observed, and it might be
derived from an alternative polyadenylation of the gene. The
FIG. 3. Expression of SLC26A7–A9
in human kidney, testis, and lung, re-
spectively. Positive signal is seen
as brown color in immunohistochemical
stainings and as white (c) or black (d)
grains in in situ hybridization. a, by im-
munohistochemistry, a strong signal for
SLC26A7 is seen in the distal tubules,
whereas the proximal tubuli remain neg-
ative. b, control staining with the preim-
mune serum of the same rabbit. c, in situ
hybridization (dark field image) reveals
distinct SLC26A8 signal in the luminal
side of the seminiferous tubuli of the tes-
tis. d, a bright field image of the same
area as in c. e, control hybridization with
a sense probe gives no specific signal. f,
by immunohistochemistry, a strong
SLC26A8 signal is seen in the spermato-
cytes (arrowhead) and the spermatids (ar-
row). g, control staining with the preim-
mune serum of the same rabbit as in f. By
immunohistochemical analysis of the
lung, a strong signal for SLC26A9 is seen
in the bronchial epithelial (h) and in the
alveolar epithelial cells (j). Note the ap-
parent concentration of the protein to-
ward the alveolar space (arrows). i and k,
control stainings with the preimmune se-
rum of the same rabbit.
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long 3-untranslated region of the SLC26A7 gene contains a
number of consensus AAUAAA or AUUAAA sequences that
may serve as alternative polyadenylation signals in a reason-
able agreement with the size of the less abundant 3.0-kb
transcript. PCR analysis also showed the most abundant ex-
pression in kidney, placenta, and testis supported consistently
by the Northern analysis. Immunohistochemical experiments
were performed in order to localize the expression of SLC26A7
in the human kidney. Positive signal was consistently detected
in distal segments of nephrons, whereas the proximal tubules
remained negative (Fig. 3a).
Both Northern and PCR analyses revealed a testis-specific
distribution for SLC26A8 (Fig. 2B). The 3371-bp full-length
cDNA of SLC26A8 corresponded with the observed size (3.5
kb) in Northern analysis. More detailed cell-specific localiza-
tion of SLC26A8 was analyzed by both in situ hybridization
and immunohistochemistry in human testis. In situ hybridiza-
tion with SLC26A8 antisense cRNA probe revealed abundant
expression in the seminiferous tubules. The SLC26A8 mRNA
was concentrated on the luminal side of the tubuli harboring
the spermatocytes and the spermatids, whereas the peripheral
side of the tubuli, containing the spermatogonia, appeared
negative (Fig. 3, c–e). Consistently, immunohistochemistry
showed distinct SLC26A8 protein expression in developing
spermatocytes and spermatids (Fig. 3, f and g). Altogether, our
data suggest that the expression of SLC26A8 is restricted to
the meiotic phase of the germ cells in the human testis.
PCR analysis suggested that SLC26A9 is expressed predom-
inantly in the lung, although some expression was found also in
pancreas and prostate. The lung-specific expression of
SLC26A9 was confirmed by Northern blotting (Fig. 2C). The
4815-bp full-length cDNA of SLC26A9 corresponded with the
observed size (4.8 kb) in Northern analysis. To refine the
expression results, we used RT-PCR to study two human lung-
specific epithelial cell lines, NCI-H358 and A549, from bron-
choalveolus and alveolus, respectively (Fig. 2C). Both cell lines
expressed SLC26A9. Furthermore, immunohistochemical
stainings with SLC26A9 antisera revealed strong cytoplasmic
staining in the bronchiolar (Fig. 3h) as well as the alveolar
epithelium (Fig. 3j). Apparent membrane-associated accumu-
lation of the signal was observed in the alveoli.
Functional Analyses of SLC26A7–A9—To characterize the
function of the proteins encoded by SLC26A7–A9, in vitro tran-
scribed cRNAs of SLC26A7–A9 were injected into X. laevis
oocytes, and function was measured by [35S]sulfate, [36Cl]chlo-
ride, and [14C]oxalate uptakes. The expression of all three
proteins separately led to the induction of chloride, sulfate, and
oxalate transport above water-injected (control) oocytes (Fig. 4,
a–c). Moreover, the SLC26A9-mediated sulfate transport was
inhibited by the anion exchanger inhibitor DIDS and thiosul-
fate but not by oxalate or glucose (Fig. 4d). Similar inhibition of
sulfate transport of SLC26A8 by DIDS was observed previously
(16). These results demonstrate that SLC26A7–A9 proteins
function as anion exchangers mediating at least chloride, sul-
fate, and oxalate transport.
DISCUSSION
A growing interest in the SLC26 family of anion exchangers
is stimulated by the involvement of the first three members,
SLC26A2–A4, in distinct human genetic diseases, the existence
of new tissue-specific members, additional functionalities such
as the motor activity of SLC26A5, and the concept that trans-
port proteins may be organized in membrane microdomains
through specific interacting proteins (2, 7, 14). In this report,
we describe the functional characterization of three new tissue-
specific members, designated SLC26A7–A9 (Table I).
The SLC26A7–A9 proteins are highly homologous to the
previously known members as illustrated by multiple align-
ment of the proteins and also very similar to other genes for
their genomic organization (Table II). The SLC26A7–A9 genes
have 19–21 coding exons, and most of the exons are of similar
size to the corresponding coding exons of the others. Phyloge-
FIG. 4. Functional activity of
SLC26A7–A9 in Xenopus oocytes. Oo-
cytes were injected with 50–100 nl of wa-
ter (open bars), SLC26A7 (A7), SLC26A8
(A8), or SLC26A9 (A9) cRNAs (7–12 ng
per oocyte; filled bars). Transport of
[36Cl]chloride (a), [35SO4
]sulfate (b), and
[14C]oxalate (c) uptake was performed
(see “Experimental Procedures”). Inhibi-
tion of SLC26A9-induced sulfate trans-
port by 1 mM DIDS, 5 mM thiosulfate, 5
mM oxalate, or 5 mM glucose (d). Data are
shown as means 	 S.E. for 7–10 oocytes
per experiment and are representative of
three repeated experiments. Statistical
significance was tested using the un-
paired t test, and significance levels are
indicated by asterisks (*, p  0.05; **, p 
0.01; and ***, p  0.0001). Asterisks rep-
resent significance versus control (water),
except in d, where groups are compared
with the A9 group.
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netic analysis of the human, D. melanogaster, and C. elegans
family members illustrates the relationship of the exchangers
with each other (Fig. 5). The SLC26 family members are
mainly divided into three separate groups according to species.
However, the human SLC26A1 and SLC26A2 proteins sepa-
rate to their own branch in the phylogenetic tree (Fig. 5).
Structurally these two proteins resemble each other, and their
genomic structures are also very similar with three to four
exons, which differs from the other human members that con-
sisted of about 20 exons. Diverging exon structure of SLC26A1
and -A2 suggests that they may have lost most of their introns
during evolution and evolved from a duplication event, al-
though they have different chromosomal locations at 5q32 and
4p16, respectively (4, 7). A similar but more recent duplication
event has been suggested for the SLC26A3 and -A4 genes,
which reside within 40 kb of each other in chromosome 7 (5).
Despite the structural similarities, the SLC26 genes have
markedly different tissue expression patterns. The distribution
of SLC26A3 and SLC26A4 is specific for the affected organs in
congenital chloride diarrhea and Pendred syndrome, respec-
tively (5, 6). However, SLC26A2 expression is not restricted to
the affected cartilage, but it can be found from many other
tissues as well (4, 36). SLC26A5 is specifically expressed in the
outer hair cells of the cochlea of gerbil (13) and SLC26A6
mainly in kidney and pancreas (7). Interestingly, SLC26A7–A9
showed highly tissue-specific expression in kidney, testis, and
lung, respectively. The immunohistochemical localization and
functional characterization of SLC26A7–A9 as novel chloride,
sulfate, and oxalate transporters may cast more light on the
anion transport systems in these tissues.
The kidney is the major organ responsible for maintaining
electrolyte balance and acid-base homeostasis in mammals.
This is accomplished mainly by absorption of NaCl and secre-
tion of acid or base equivalents in different segments of the
nephron (37). Even though functional studies have character-
ized these exchangers, their molecular identities have re-
mained largely unknown (38–40). We show here that the
SLC26A7 protein is principally expressed in the distal seg-
ments of the nephrons and mediates chloride, sulfate, and
oxalate transport. These results support the hypothesis that
SLC26A7 may act as a distal excretory segment-specific anion
exchanger, playing a role in the maintenance of the electrolyte
and acid-base homeostasis in human kidney.
In situ hybridization and immunodetection experiments
showed that SLC26A8 is exclusively expressed in the sper-
matocytes and in the developing spermatids, since we did not
detect significant immunostaining in the spermatogonia. These
results suggest that the expression of SLC26A8 is restricted to
the meiotic phase of the development of the spermatogenic
cells. The extensive morphological changes observed during
spermatogenesis suggest that adequate regulation of intracel-
lular ions might be a critical component of this differentiation
process. Because SLC26A8 demonstrated chloride, sulfate, and
oxalate transport activities, our results suggest its function as
a novel male germ cell-specific anion exchanger, which may
fulfill critical functions in male germ line. This raises the
intriguing possibility that its mutations might result in im-
paired spermatogenesis in human. Furthermore, our results
are consistent with the previous characterization of TAT1,
which was published during the processing of this manuscript
(16). Our results identify TAT1 and SLC26A8 as the same gene
and confirm the previous observation regarding its expression
and function.
Functional characterization of SLC26A9 as a DIDS-inhibited
anion exchanger mediating chloride, sulfate, and oxalate trans-
port casts more light into the anion transport physiology of
human lung. The regulation of ion transport and airway sur-
face liquid is an important part of lung defense mechanisms
and may contribute to different airway diseases (41). Recent
studies (42) suggest that the composition of airway surface
liquid is regulated by active ion transport systems. In cystic
fibrosis, abnormal ion transport results in a characteristic syn-
drome with retained secretions, bacterial infection, and lung
destruction (43). Here we show that SLC26A9 is expressed both
in the alveolar and the bronchial epithelium of the human lung.
Thus, defects in the chloride or sulfate transport function of
SLC26A9 in human respiratory epithelium make it a plausible
candidate for diseases of the human respiratory system.
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FIG. 5. Phylogenetic analysis of the SLC26 family. The amino
acid sequences of the human, D. melanogaster, and C. elegans exchang-
ers were retrieved from GenBankTM and aligned with ClustalX to
generate a phylogenetic tree. The length of the branches reflects the
number of substitutions between the sequences. Homology searches
with the completed genome of D. melanogaster using known amino acid
sequences of the SLC26 members revealed that it has nine members of
this family. The numbering of the protein sequences of D. melanogaster
and C. elegans (DROSO1, DROSO2 . . . , ELE1, ELE2 . . . , respectively)
was based on the amino acid similarity with the human SLC26A3
protein by BLASTP E values so that the closest ortholog of SLC26A3
was assigned number 1 and so on. The GenBankTM accession numbers
for the protein sequences of D. melanogaster are AAF49285, AAF56989,
AAF57797, AAF55195, AAG22176, AAG22321, AAF56347, AAF55215
and AAF57068; for C. elegans T27820, T23629, T23628, T26165,
T16077, Q94225, and T32945, respectively.
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